(Reuters) - The pharmaceutical company plans to list on the Nasdaq
under the symbol "SCMP," it said in a filing with the U.S.
Securities and Exchange Commission.
Sucampo said it expects to raise net proceeds of about
$38.6 million and plans to use the proceeds to fund its
clinical trials.
Read more at Reuters.com Government Filings News
under the symbol "SCMP," it said in a filing with the U.S.
Securities and Exchange Commission.
Sucampo said it expects to raise net proceeds of about
$38.6 million and plans to use the proceeds to fund its
clinical trials.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment